PATENT CLAIM ANALYSIS

Application Number: 16075200
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "275000"]

Abstract:
The present invention relates to the field of medicine, specifically the field of treatment and prevention of cardiovascular diseases.

Claim (Index 1):
A compound that inhibits 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase while not inhibiting mitochondrial complex III, wherein said compound has the general formula I: wherein Q is selected from \u2014CH 2 \u2014 or a bond, wherein R\u2032 is selected from the group consisting of: wherein R is a substituted or non-substituted moiety selected from the group consisting of hydroxamic acid, tetrazole, nitro, thiocarboxylic acid, amide, sulfonic acid, sulfonamide, phosphonate, boronic acid, 4-linked 3-hydroxycyclobut-3-ene-1,2-dione, an oxo-oxadiazole-like moiety with optional sulfur-substitutions, and moieties having a general formula II or III: wherein X and X\u2032 and X\u2033 are each individually N, CH, or C\u2014OH, wherein Y is O, S, NH, or N\u2014CH 3 , wherein Z, Z\u2032, Z\u2033, and Z\u2032\u2033 are each individually O, S, NH, or CH 2 .

Metadata:
- Claim Count in Document: 22.0
- Percentile: 96.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12097192', '15124654', '14385808', '10676436', '15048865']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8027715568917014
- 35 USC 102 Novelty (BERT): 0.509592490750844
- Combined Prediction Score: 0.7734536502776157
- Mean Citation Score: 239.786522
- Max Citation Score: 243.80318
- Similarity Product: 146.408384084996

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test